Uncategorized
Next-Generation Antibody-Drug Conjugates in Gynecologic Oncology
Introduction The landscape of gynecologic oncology is undergoing a paradigm shift driven by the emergence of next-generation antibody-drug conjugates (ADCs). Says Dr. Scott Kamelle, historically, patients
